Approvals/TGA/Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Approved

STANDARD

Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6df215a08f2ba0b7
Product Name: Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Artg Id: 328527
Artg Name: Nab-PACLITAXEL JUNO Paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2020-10-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-02348-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02477-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

6df215a08f2ba0b7

Type

Standard